CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2017	Mar. 31, 2017
ASSETS
Cash and cash equivalents	$ 30,203,773	$ 8,664,211
Accounts receivable, net of allowance for doubtful accounts of $381,019 and $475,080, respectively	4,857,136	5,506,472
Other receivables	372,334	464,085
Due from affiliates	0	18,314
Prepaid expenses and other current assets	298,477	269,168
Total current assets	35,731,720	14,922,250
Property and equipment, net	1,121,632	1,205,139
Restricted cash	745,176	765,058
Intangible assets, net	1,732,984	1,904,269
Goodwill	1,622,483	1,622,483
Other assets	219,174	225,358
TOTAL ASSETS	41,173,169	20,644,557
LIABILITIES AND STOCKHOLDERS’ EQUITY
Accounts payable and accrued liabilities	7,042,043	7,883,373
Medical liabilities	30,694,173	1,768,231
Convertible note payable, net of debt issuance cost of $53,667 and $161,000, respectively	4,936,333	4,829,000
Lines of credit	25,000	62,500
Total current liabilities	42,697,549	14,543,104
Note payable - related party	5,000,000	5,000,000
Deferred rent liability	683,504	747,418
Deferred tax liability	83,666	83,667
TOTAL LIABILITIES	48,464,719	20,374,189
COMMITMENTS AND CONTINGENCIES (see Note 8)
STOCKHOLDERS’ (DEFICIT) EQUITY
Common stock, par value $0.001; 100,000,000 shares authorized; 6,052,518 and 6,033,518 shares issued and outstanding, respectively	6,053	6,033
Additional paid-in capital	26,836,238	26,331,948
Accumulated deficit	(45,148,985)	(37,654,381)
Stockholders’ deficit attributable to Apollo Medical Holdings, Inc.	(7,344,171)	(353,877)
Non-controlling interest	52,621	624,245
Total stockholders’ (deficit) equity	(7,291,550)	270,368
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY	41,173,169	20,644,557
Series A Preferred Stock [Member]
STOCKHOLDERS’ (DEFICIT) EQUITY
Preferred Stock Value	7,077,778	7,077,778
Series B Preferred Stock [Member]
STOCKHOLDERS’ (DEFICIT) EQUITY
Preferred Stock Value	$ 3,884,745	$ 3,884,745